These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6121091)

  • 1. Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy.
    Burns WH; Saral R; Santos GW; Laskin OL; Lietman PS; McLaren C; Barry DW
    Lancet; 1982 Feb; 1(8269):421-3. PubMed ID: 6121091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.
    Wade JC; McLaren C; Meyers JD
    J Infect Dis; 1983 Dec; 148(6):1077-82. PubMed ID: 6317768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
    Christophers J; Sutton RN
    J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
    Sibrack CD; McLaren C; Barry DW
    Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections.
    Chou S; Gallagher JG; Merigan TC
    Lancet; 1981 Jun; 1(8235):1392-4. PubMed ID: 6113353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.
    Mitchell CD; Bean B; Gentry SR; Groth KE; Boen JR; Balfour HH
    Lancet; 1981 Jun; 1(8235):1389-92. PubMed ID: 6113352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
    Field HJ; Neden J
    Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
    Shepp DH; Newton BA; Dandliker PS; Flournoy N; Meyers JD
    Ann Intern Med; 1985 Jun; 102(6):783-5. PubMed ID: 2986508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies of drug resistance in herpes simplex.
    Field HJ; Darby GK
    Nature; 1980 Aug; 286(5776):842. PubMed ID: 6251373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
    Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.
    Field HJ; Darby G; Wildy P
    J Gen Virol; 1980 Jul; 49(1):115-24. PubMed ID: 6252285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
    Darby G; Field HJ; Salisbury SA
    Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ; Taylor JL
    Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 20. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.